
    
      1. Prospective, randomized, head-to-head, double-blind, cross-over study.

        2. Total patients: A group 51, B group 51

        3. Study duration: 16 + 4 + 16 weeks. Eligible patients will be randomised at baseline to
           receive either Dysport® or Botox® and monitored at weeks 2, 4, 8, 12, 16 weeks. After 4
           weeks of wash out period, then the patients get the other treatment (i.e, Patients who
           have got Dysport will be then administered with Botox)

        4. Compare the TSUI change score from baseline to 4 weeks after injection.
    
  